Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2475 of 3284 entries
View as:

A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7503 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05143905 Org: User:
Start: 12/06/21 End: 11/09/22 Due: 11/09/23

The IRESSA Novel Head and Neck Chemotherapy Evaluation Study

Phase: N/A Priority: Normal
NCT ID: NCT00255476 Org: User:
Start: 02/29/04 End: 07/31/07 Due: 07/31/08

A Methodology Study in Healthy Subjects to Evaluate the Effect of AZD8309 After Nasal Administration of Lipopolysaccharide (LPS)

Phase: N/A Priority: Normal
NCT ID: NCT00860821 Org: User:
Start: 03/31/09 End: 10/31/09 Due: 10/31/10

Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease.

Phase: N/A Priority: Normal
NCT ID: NCT02606851 Org: User:
Start: 12/04/15 End: 12/28/16 Due: 12/28/17

Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01046630 Org: User:
Start: 12/31/09 End: 03/31/11 Due: 03/31/12

Study to Compare Two Formulations of CP-675,206 Monoclonal Antibody

Phase: N/A Priority: Normal
NCT ID: NCT00431275 Org: User:
Start: 06/30/06 End: 02/29/08 Due: 02/28/09

Retrospective Treatment Pattern Survey for the Patients With Hypertension and Stroke

Phase: N/A Priority: Normal
NCT ID: NCT00681707 Org: User:
Start: 05/31/08 End: 07/31/08 Due: 07/31/09

10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI)

Phase: N/A Priority: Normal
NCT ID: NCT00885612 Org: User:
Start: 05/31/09 End: 03/31/10 Due: 03/31/11

Single Centre, Double-blind, Single and Multiple Ascending Inhaled Doses of AZD9819 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01166698 Org: User:
Start: 08/31/10 End: 01/31/11 Due: 01/31/12

Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist

Phase: N/A Priority: Normal
NCT ID: NCT06851858 Org: User:
Start: 03/12/25 End: 01/27/26 Due: 01/27/27

A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00661609 Org: User:
Start: 05/31/08 End: 12/31/09 Due: 12/31/10

Crestor RUSH (The Efficacy of RosUvaStatin for Korean Dyslipidemia Patients With Hypertension )

Phase: N/A Priority: Normal
NCT ID: NCT00526708 Org: User:
Start: 05/31/07 End: 11/30/07 Due: 11/30/08

Relative Bioavailability Study in Healthy Male Subjects for ZD4054 (Zibotentan) Immediate Release Tablets.

Phase: N/A Priority: Normal
NCT ID: NCT00713791 Org: User:
Start: 06/30/08 End: 08/31/08 Due: 08/31/09

eVusheld Assessment reaL wORld Effectiveness at UPMC

Phase: N/A Priority: Normal
NCT ID: NCT05667116 Org: User:
Start: 01/09/23 End: 07/24/23 Due: 07/24/24

A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2

Phase: N/A Priority: Normal
NCT ID: NCT05737940 Org: User:
Start: 04/24/23 End: 08/26/25 Due: 08/26/26

Faslodex Advanced Breast Cancer Local Chinese Study

Phase: N/A Priority: Normal
NCT ID: NCT00327769 Org: User:
Start: 11/30/05 End: 09/30/07 Due: 09/30/08

ATAC - Endometrial Sub-Protocol

Phase: N/A Priority: Normal
NCT ID: NCT00814125 Org: User:
Start: 06/30/97 End: 12/31/05 Due: 12/31/06

Efficacy, Safety, and Tolerability of Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-38)

Phase: N/A Priority: Normal
NCT ID: NCT01045161 Org: User:
Start: 03/31/09 End: 06/30/11 Due: 06/30/12

Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403)

Phase: N/A Priority: Normal
NCT ID: NCT00163514 Org: User:
Start: 05/31/04 End: 07/31/05 Due: 07/31/06

Dose-escalation Study to Assess Selumetinib Safety, Tolerability and PK

Phase: N/A Priority: Normal
NCT ID: NCT01960374 Org: User:
Start: 10/31/13 End: 05/31/14 Due: 05/31/15

Study of MEDI4736 (Durvalumab) With or Without Tremelimumab Versus Standard of Care Chemotherapy in Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02516241 Org: User:
Start: 11/02/15 End: 12/31/25 Due: 12/31/26

A Study to Assess the Bioavailability and to Compare the Pharmacokinetics of AZD7594 Inhaled Via Monodose Inhaler and Multiple-dose Dry Powder Inhalers (DPI) or Pressurized Metered-dose Inhaler (pMDI) in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02648438 Org: User:
Start: 01/12/16 End: 06/01/16 Due: 06/01/17

Evaluation of the Pharmacokinetics and the Pharmacodynamics of Different Dry Powder Inhalation Formulations of AZD3199 in Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01348139 Org: User:
Start: 05/31/11 End: 02/29/12 Due: 02/28/13

Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00444561 Org: User:
Start: 08/31/04 End: 05/31/05 Due: 05/31/06

A Study to Assess the Pharmacokinetics and Safety of Single Doses of Anifrolumab in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02601625 Org: User:
Start: 11/16/15 End: 05/25/16 Due: 05/25/17